PL2992332T3 - Sposób in vitro wczesnego wykrywania potencjalnego zapalenia związanego z odrzucaniem przeszczepu - Google Patents

Sposób in vitro wczesnego wykrywania potencjalnego zapalenia związanego z odrzucaniem przeszczepu

Info

Publication number
PL2992332T3
PL2992332T3 PL14721366T PL14721366T PL2992332T3 PL 2992332 T3 PL2992332 T3 PL 2992332T3 PL 14721366 T PL14721366 T PL 14721366T PL 14721366 T PL14721366 T PL 14721366T PL 2992332 T3 PL2992332 T3 PL 2992332T3
Authority
PL
Poland
Prior art keywords
transplant
rejection
early detection
vitro method
inflammation associated
Prior art date
Application number
PL14721366T
Other languages
English (en)
Inventor
Dietmar Abendroth
Manfred J. Stangl
Michael Marzinzig
Original Assignee
Salion Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salion Gmbh filed Critical Salion Gmbh
Publication of PL2992332T3 publication Critical patent/PL2992332T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/64—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7057—(Intracellular) signaling and trafficking pathways
    • G01N2800/7066—Metabolic pathways
    • G01N2800/7076—Amino acid metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7095—Inflammation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
PL14721366T 2013-05-03 2014-05-02 Sposób in vitro wczesnego wykrywania potencjalnego zapalenia związanego z odrzucaniem przeszczepu PL2992332T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13166375.9A EP2799878A1 (en) 2013-05-03 2013-05-03 In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
PCT/EP2014/058965 WO2014177680A1 (en) 2013-05-03 2014-05-02 In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant, a neurodegenerative disorder or a depression
EP14721366.4A EP2992332B1 (en) 2013-05-03 2014-05-02 In vitro method for the early detection of a potential inflammation associated with rejection of a transplant

Publications (1)

Publication Number Publication Date
PL2992332T3 true PL2992332T3 (pl) 2020-08-10

Family

ID=48227033

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14721366T PL2992332T3 (pl) 2013-05-03 2014-05-02 Sposób in vitro wczesnego wykrywania potencjalnego zapalenia związanego z odrzucaniem przeszczepu
PL19153222.5T PL3499240T3 (pl) 2013-05-03 2014-05-02 Metoda in vitro wczesnego wykrywania zaburzeń neurodegeneracyjnych lub depresji z wykorzystaniem kynureniny jako markera

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL19153222.5T PL3499240T3 (pl) 2013-05-03 2014-05-02 Metoda in vitro wczesnego wykrywania zaburzeń neurodegeneracyjnych lub depresji z wykorzystaniem kynureniny jako markera

Country Status (12)

Country Link
US (1) US9983212B2 (pl)
EP (3) EP2799878A1 (pl)
JP (2) JP6449247B2 (pl)
KR (1) KR102198869B1 (pl)
CN (1) CN105164537B (pl)
AU (1) AU2014261333B2 (pl)
CA (1) CA2910315C (pl)
DK (1) DK2992332T3 (pl)
ES (2) ES2988827T3 (pl)
PL (2) PL2992332T3 (pl)
PT (1) PT2992332T (pl)
WO (1) WO2014177680A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3906952A1 (en) 2012-10-11 2021-11-10 Magnolia Medical Technologies, Inc. Systems and methods for delivering a fluid to a patient with reduced contamination
EP3070475B1 (en) 2015-03-18 2020-02-19 Karl-Heinz Kellner In vitro diagnostic, prognosis of contrast induced nephropathy
JP6757037B2 (ja) * 2016-02-15 2020-09-16 学校法人近畿大学 ストレス評価方法
WO2018056431A1 (ja) * 2016-09-26 2018-03-29 池田食研株式会社 L-キヌレニンの測定方法及び測定キット
EP3413050A1 (en) 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
KR102660904B1 (ko) * 2017-06-28 2024-04-25 벡톤 디킨슨 앤드 컴퍼니 고농도의 분석물을 포함한 분석물을 측정하기 위한 용량 반응 곡선의 신호 부분을 감소시키는 단계를 사용하는 샌드위치-유형 분석법
WO2019147853A1 (en) * 2018-01-27 2019-08-01 Becton, Dickinson And Company Multiplex lateral flow assay for differentiating bacterial infections from viral infections
CN111801575B (zh) * 2018-01-27 2024-01-12 贝克顿·迪金森公司 区分细菌感染和病毒感染的多重横向流测定物
WO2019181830A1 (ja) * 2018-03-19 2019-09-26 富士フイルム和光純薬株式会社 精神疾患の判定方法
WO2021119487A1 (en) * 2019-12-11 2021-06-17 Magnolia Medical Technologies, Inc. Fluid transfer devices with integrated flow-based assay and methods of using the same
EP4266057B1 (en) 2022-04-20 2026-04-01 SALION GmbH Kynurenine: useful biomarker in acute covid-19 and long covid
JPWO2024253194A1 (pl) * 2023-06-08 2024-12-12
CN117224519A (zh) * 2023-09-26 2023-12-15 广西大学 L-犬尿氨酸作为一种免疫调节剂在器官移植中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854934A4 (en) * 1995-08-18 2000-09-06 Donald W Landry DETECTION OF ORGANIC COMPOUNDS BY REGULATION OF ANTIBODY CATALYZED REACTIONS
US5871905A (en) * 1996-09-04 1999-02-16 Epitope, Inc. Reduction of false positives in oral-fluid based immunoassays
US6102872A (en) * 1997-11-03 2000-08-15 Pacific Biometrics, Inc. Glucose detector and method
GB0400976D0 (en) * 2004-01-16 2004-02-18 Univ Cambridge Tech Methods of diagnosis
ES2261049B1 (es) * 2004-12-16 2007-11-01 Proyecto De Biomedicina Cima, S.L. Dioagnostico de carcinoma hepatocelular mediante la deteccion de formas oxidadas de apolipoproteina a1.
EP2146209B1 (en) * 2005-04-06 2011-11-16 University of Antwerp Neurodegenerative markers for Alzheimer's disease
HUP0700051A2 (en) * 2007-01-17 2008-09-29 Univ Szegedi Use of kynurenic acid and derivatives there of for treating of gastrointestinal disorders associated with enhanced motility and inflammation
WO2008108994A1 (en) * 2007-03-01 2008-09-12 Carnegie Institution Of Washington Trp/his exchange and kynurenine induced trp transport
EP2284540A1 (en) * 2009-07-31 2011-02-16 BIOCRATES Life Sciences AG Method of diagnosing organ failure
EP2466312B1 (en) 2009-08-12 2019-10-16 Human Metabolome Technologies, Inc. Phosphoethanolamine as biomarker of depression
EP2492690A1 (en) * 2011-02-22 2012-08-29 BIOCRATES Life Sciences AG Method and use of metabolites for the diagnosis of inflammatory brain injury in preterm born infants

Also Published As

Publication number Publication date
CN105164537A (zh) 2015-12-16
EP3499240B1 (en) 2024-07-03
EP3499240C0 (en) 2024-07-03
PT2992332T (pt) 2020-02-19
ES2771475T3 (es) 2020-07-06
EP2992332B1 (en) 2019-11-06
DK2992332T3 (da) 2020-02-17
AU2014261333B2 (en) 2019-09-12
KR20160004378A (ko) 2016-01-12
EP2799878A1 (en) 2014-11-05
WO2014177680A1 (en) 2014-11-06
US20160084843A1 (en) 2016-03-24
KR102198869B1 (ko) 2021-01-06
ES2988827T3 (es) 2024-11-21
EP3499240A1 (en) 2019-06-19
JP2016520827A (ja) 2016-07-14
CA2910315C (en) 2022-05-03
PL3499240T3 (pl) 2024-12-02
CA2910315A1 (en) 2014-11-06
JP2019060880A (ja) 2019-04-18
US9983212B2 (en) 2018-05-29
EP2992332A1 (en) 2016-03-09
AU2014261333A1 (en) 2015-11-19
JP6449247B2 (ja) 2019-01-09
CN105164537B (zh) 2017-12-01

Similar Documents

Publication Publication Date Title
PT2992332T (pt) Método in vitro para a deteção precoce de uma potencial inflamação associada à rejeição de um transplante
PT3563793T (pt) Aparelho de contenção, bem como processo para a sua produção
EP2988854A4 (en) Channeled articles and methods for their manufacture
EP2891554A4 (en) METAL STRUCTURE AND MANUFACTURING METHOD THEREFOR
AU353978S (en) Stent
GB201223450D0 (en) Search and corresponding method
GB201402763D0 (en) Foreign language title
SG11201600641UA (en) Stent
IL245392A0 (en) A method for cell culture
SG11201508847WA (en) Electroformed component and method for manufacturing same
EP2961825A4 (en) STRUCTURE FOR CULTIVATION OF CELLS
IL240781A0 (en) Stent
GB2532385B (en) Cell synchronization and synchronization cell indication
GB201400089D0 (en) Stents and apparatus and method for manufacturing the same
IL240782A0 (en) Stent
ZA201507023B (en) Method and plant for the production of methane
EP2980873A4 (en) CRYOSTAT
PL2967936T3 (pl) Stent skośny
EP2977030A4 (en) STENT
GB201311849D0 (en) Super-hard constructions and methods for making and processing same
EP3073272A4 (en) Method for automatic in vitro diagnosis
EP2987470A4 (en) ENDOPROTHESIS AND METHOD FOR PRODUCING SAME
EP2982391A4 (en) STENT
GB2512119B (en) Cryostat inspection camera arrangement and method
GB201607562D0 (en) Process tracking and defect detection